Overview A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder Status: Completed Trial end date: 2019-03-18 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety and efficacy in patients with major depressive disorder. Phase: Phase 2 Details Lead Sponsor: BioLite, Inc.